Assyro AI
Orange Book product · Brand (NDA)

Advil Allergy Sinus

Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride

Brand (NDA)NDA 021441RLD Haleon US Holdings
Approved
Dec 19, 2002
Application
Brand (NDA)
TE code
Not listed
Listed patents
1
Advil Allergy Sinus (Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride) is Haleon US Holdings's brand-name drug, approved by the FDA under NDA 021441 in 2002. It is a reference-listed drug (RLD) — the approved product that generic ANDA applicants must show their version is equivalent to. The FDA Orange Book lists 1 patent against it, the last expiring 2027.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 19, 2002

    23 yr 11 mo ago

  2. Today

  3. Patent 7863287 expires

    Listed drug product patent expiration.

    Feb 28, 2027

    in 8 mo

Protection horizon

Patent & exclusivity timeline

202620272028TodayPatent 7863287 — 2027-02-28Patent 7863287
Patent expiryExclusivity endToday
FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Strength

2MG;200MG;30MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 021441

Product number

001

Marketing status

Over-the-counter

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Brand + generics

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

View full Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride family
Orange Book patent file

Listed patents

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7863287Feb 28, 2027in 8 mo
Product

Advil Allergy Sinus — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.